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Abstract
In the context of global aging, HIV infection has become a new chronic disease and requires innovative models of
care. Treating isolated comorbidities represents a useless and potentially harmful practice at advanced age.
Therefore, a patient-centered approach, in which the interventions are focused on the biology and function of the
individual, with understanding of the importance of securing social and home environment that provides
psychosocial support, better suits unmet health needs. We present a paradigmatic case of healthy aging: the first
reported HIV-infected patient who achieved 100th of life – the Lisbon patient. The construct of healthy aging,
recently introduced by the World Health Organization, is the best example of this comprehensive model and could
represent the fourth target of UNAIDS agenda of the end of AIDS.
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Background
Epidemiological models suggest that life expectancy of
people living with HIV achieving immunological success
is similar to that of the general population [1], neverthe-
less the clinical experience of extreme longevity is still
limited.
This review gets inspiration from the first reported,
and presumably not unique, 100-year-old HIV-infected
person, to discuss new principles of geriatric medicine
that could be applied in HIV setting. We will use this
case as a paradigm to identify opportunities in joining
HIV and geriatric medicine to improve the care of older
people living with HIV (OPLWH). We obtained consent
to present this case from patient’s daughter.
The hereby called “Lisbon patient” was diagnosed with
HIV infection at the age of 84, and peacefully died in his
sleep 4 months after turning 100 years.
The date of HIV acquisition was not known; at the
time of diagnosis, he presented with non-Hodgkin
lymphoma and CMV colitis. Nadir CD4 T cell count
was < 100 c/μL.
He started antiretroviral therapy (ART) immediately
after being diagnosed and was exposed to chemotherapy
and toxic ART drugs, including zidovudine, stavudine
and first-generation protease inhibitors. He has achieved
an undetectable level of HIV-RNA since the beginning
of HIV treatment up to death. His last available CD4+
T-lymphocyte count were 560 cells/μL (34%) with CD4/
CD8 = 0.97.
From a geriatric perspective, the Lisbon patient had
multi-morbidity with hypertension, liver steatosis,
osteoarthrosis, and benign prostate hypertrophy. With
regards to geriatric syndromes he had sarcopenia and
was phenotypically frail [2], due to muscle weakness,
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slow gait speed, and sedentariness. He had no polyphar-
macy: the only drug he was taking (apart from ART) was
antihypertensive medication. His cognitive function was
normal (as estimated by MOCA score).
He had a fortunate genetic inheritance given that his
father and siblings reached more than 90 years of age.
He had been living in a good environment with no
socio-economic difficulties with support and love of his
daughter who took care of him (even though she is 75
years old).
Main text
The number of OPLWH is increasing thanks to the syn-
ergistic result of two phenomena: people living with HIV
live longer and more people acquire HIV at an older age
[3]. The former is represented by OPLWH that have
been longer exposed to antiretroviral regimens with
harmful metabolic effects leading to accentuated risk for
co-morbidities, while the latter comprises OPLWH with
lower perception of sexual risk that might have devel-
oped co-morbidities that are not HIV-associated [4, 5].
To better characterize the diversity of OPLWH, aging
cohorts are rising across Europe to address similarities
and differences with the complexity of aging trajectories
in the general population [5].
In the context of global aging, HIV infection repre-
sents a new chronic disease in which the principles of
geriatric medicine should be applied. Relevant clinical
outcomes go far beyond immune-virologic parameters
or even age-related non-infectious co-morbidities alone
[6] and include geriatric syndromes. They are multifac-
torial health conditions that occur when the accumu-
lated deficits in multiple systems, at a clinical level most
commonly represented by frailty. It describes a lack of
homeostatic reserves exposing the individual to a higher
risk of negative outcomes [7].
Frailty assessment allows to identify the causes of indi-
vidual’s increased vulnerability and implement a person-
tailored intervention plan, called comprehensive geriatric
assessment.
The new EACS guidelines recommend screening of
OPLWH for frailty in the context of a Comprehensive
Geriatric Assessment (CGA) [8], defined as a multidis-
ciplinary diagnostic and treatment process that identifies
medical, psychosocial, and functional limitations of a
frail older person to develop a coordinated plan to
maximize overall health with aging [6, 9].
Healthy aging was described in the World report on
Aging and Health, developed by World Health
Organization, as the process of developing and maintain-
ing the functional ability that enables well-being in older
age [10].. This construct relies on the interplay between
intrinsic capacity (IC), that includes all physical and cog-
nitive functions of an individual, and the environment.
Healthy aging is influenced by our genetic inheritance
and personal characteristics such as sex, ethnicity, edu-
cation and occupation [10]. Assessing IC is both a multi-
disciplinary and multidimensional process, designed to
evaluate the individual’s characteristics on the basis of
five functional domains: locomotion, cognitive, psycho-
logic, vitality-related and sensory [11].
Moreover, the IC might be considered as an evolution
of the frailty concept, as it takes into special consider-
ation functional reserves expressed by vitality domain,
the need for a worldwide implementation of prevention,
the continuum of the aging process [11]. This novel ap-
proach provides a few advantages over frailty as it gives
a positive connotation to the aging phenomenon, pro-
vides a possibility to better describe aging trajectories in-
stead of using cross-sectional cut-points and promotes
self-empowerment of the individual for his/her health
[12].
Both frailty and IC are based on the assumption that
the aging individual need to be assessed and managed in
a patient centered model through integration of multi-
disciplinary health services and data obtained by the
health environment of the subject [12].
This geriatric approach changes the medical perspec-
tive from disease management to preservation of health
status maintaining the individual’s functional ability,
thus having the capabilities that enable all people to be
and do what they have reason to value. This includes a
person’s ability to meet their basic needs, to learn, grow
and make decisions, to be mobile, to build and maintain
relationships, and to contribute to society [10].
IC domains, except for sensory function, were all pre-
served in the Lisbon patient. Considering the environ-
mental part of healthy aging, we can say that the Lisbon
patient had been living in a favorable environment that
allowed him to achieve longevity. He taught us that it is
possible experience healthy aging regardless of being af-
fected by HIV as a chronic condition. We might indeed
consider our ‘Lisbon patient’ as an icon inspiring scien-
tific and community commitment.
However, there is still a lot to be done, as we are
seeking for the reliable healthy aging and IC tool.
The WHO has launched the Integrated Care for
Older People (ICOPE) guidelines with the aim to as-
sist health care professionals to identify declines in
physical and mental capacity and to deliver effective
interventions to prevent and delay progression of dis-
ease and disability [13, 14]. Health care services
should meet the needs of those with declining IC, but
also of those with preserved IC.
In HIV scenario, OPLWH may present a similar viro-
immunological status, but completely different health
needs that require different intensity of care [14]. This
approach leads to tailored interventions taking into an
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account management of ART and co-morbidities, social
care and preservation of IC [15].
The Joint United Nations Program on HIV/AIDS
(UNAIDS) launched the agenda for the end of AIDS
introducing the “90–90–90 targets” [16]. This program
introduces an equity principle for HIV care. Lazarus
et al. suggested to add a fourth 90% in the 90–90-90 cas-
cade paradigm: 90% of all virally suppressed patients
should reach good quality of life [17]. The idea of intro-
ducing quality of life as the major outcome in people liv-
ing with HIV originates from the era of first ART
regimens, when it was proposed as a part of the evalu-
ation of new and existing treatment strategies [18].
Conclusions
In a patient related outcome context, quality of life may
represent a valuable contribution focusing on the sub-
jective perception of the individual’s status and implicitly
based on his socio-cultural and economic environment.
The limit of this patient-related outcome is that it may
fail to represent a robust and standardized parameter for
driving public health decisions. Furthermore, quality of
life is not necessarily related to the functional compe-
tence of the aging individual, as depicted by the Lisbon
Patient’s suboptimal quality of life, assessed by the EQ-
5D-5 L questionnaire [19].
On the other hand, healthy aging, although designed
for the general population, can perfectly fit to OPLWH,
as it reinforces a patient-centered approach and asks for
a reshaped healthcare model. An integrated model that
includes community, the patient, and healthcare pro-
viders could identify both medical and social needs, and
increase the possibilities for effective intervention [14].
The Lisbon patient commits us to be ambitious to add
healthy aging as the fourth target to the UNAIDS 90–
90-90 program.
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